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INTRODUCTION
Asthma is a chronic inflammatory disorder of the airways
(1), in which a CD4+ Th2 lymphocyte cytokine profile is
instrumental in initiating and sustaining the inflammatory
process (2). The CD4+ T cells need to be activated by anti-
gen presenting cells (APCs). Dendritic cells (DCs) are the
major APCs responsible for the activation of naive T cells and
the generation of primary T cell responses (3) and can also
selectively activate Th2-like lymphocytes in asthma (4, 5).
Therefore, DCs are most likely to contribute to the eosinophilic
airway inflammation in asthma. 
It has been demonstrated that DCs are critical APCs for
the eosinophilic airway inflammation in sensitized mice (6).
Upregulation of the DC network has also been suggested to
be an integral part of the eosinophilic airway inflammation
in sensitized rats (7). Recently, a study has demonstrated a
role for cysteinly leukotrienes (CysLTs) in the migration of
DCs from blood to the airway in asthmatics (8). CysLTs are
produced primarily by mast cells, basophils, and eosinophils
(9). It is reasonable to consider that DCs are closely related
to the ongoing eosinophilic airway inflammation in asthma.
Bronchial biopsies have revealed the increased numbers of
DCs in the airways of atopic (5, 10-14) and nonatopic asth-
matics (13, 14). However, sputum induction has emerged
as a useful non-invasive technique to assess the airway inflam-
mation in subjects with asthma and has been shown to return
reproducible data with regard to cellular and soluble markers
of inflammation (15, 16). We reasoned that the increased num-
ber of DCs observed in bronchial biopsies could be detected
in the induced sputum as well. Since it has been known that
the degree of eosinophil activation is more important than
the increase in number of eosinophils in reflecting the ongo-
ing inflammation in asthma (17-19), it is expected that there
is the relationship between DCs and activated eosinophils in
asthmatic airways.
The aims of the present study are to determine whether the
number of DCs is increased in the induced sputum of both
atopic and nonatopic asthmatics, and to determine whether
the number of DCs is closely related to the activated eosinophil
count in the induced sputum.
MATERIALS AND METHODS
Subjects
Nine atopic and 12 nonatopic asthmatics and 10 healthy
volunteers were included in the study. Asthma was diagnosed
on the basis of clinical history of recurrent episodes of wheeze,
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Relationship between Dendritic Cells and Activated Eosinophils in
Induced Sputum of Asthmatics
It has been suggested that dendritic cells (DCs) are critical antigen presenting
cells for eosinophilic airway inflammation in a mouse model of asthma, and cys-
teinyl leukotrienes may play a role in DC trafficking in asthmatics. We investigated
whether the number of DCs is increased in the induced sputum of both atopic and
nonatopic asthmatics and is related to activated eosinophil count in the sputum.
Sputum was induced by inhalation of hypertonic saline in 9 atopic and 12 nonatopic
asthmatics and 10 nonatopic normal controls, and differential cell counts were per-
formed. DCs and activated eosinophils were identified by immunocytochemistry
with monoclonal antibodies (anti-CD1a and EG2, respectively). There were signifi-
cantly higher percentages of eosinophils, EG2+ cells, and CD1a+ DC in the spu-
tum of atopic and nonatopic asthmatics compared with normal controls, respec-
tively. In asthmatics, the percentage of CD1a+ DC was significantly correlated
with that of EG2+ cells (Rs=0.62, p=0.004). We demonstrated that the increased
number of DCs was evident in the induced sputum of both atopic and nonatopic
asthmatics, and the DC number was related to the activated eosinophil count,
which suggests that DCs may contribute to the ongoing eosinophilic inflammation
in asthmatic airways, and vice versa.
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breathlessness and/or cough associated with the demonstra-
tion of reversible airway obstruction or bronchial hyperrespon-
siveness to methacholine. Subjects were considered to have the
significant reversibility if there was an improvement in FEV1
of >15% and 200 mL after salbutamol 200  g. The metha-
choline bronchial provocation test was done according to the
method of Chai et al. (20). The bronchial hyperresponsiveness
was defined if the provocative concentration of methacholine
that caused a 20% fall in FEV1 was <25 mg/mL (21). Atopy
was defined as a positive skin prick test (mean wheal diame-
ter ≥3 mm) to at least one of the common aeroallergens.
All asthmatics had a clinical history suggestive of asthma
for at least 3 months before the study. Asthma symptoms
were controlled with  2-adrenergic drugs on a continuous
basis or on demand. None had received oral or inhaled cor-
ticosteroids for at least 6 weeks before the study. Normal con-
trols were not taking any form of medication, had no histo-
ry of asthma or other allergic diseases, and had no skin reac-
tions to the common allergens.
All subjects had no upper respiratory tract infection with-
in the preceding 4 weeks. Nonsmoking was not a prerequi-
site for selection. All subjects gave written informed consent
for this study, which was approved by the Chonnam Univer-
sity Hospital Ethics Committee.
Sputum induction and processing
Sputum induction was performed by inhalation of hyper-
tonic saline (NaCl 4.5%) 15 min after premedication with
200  g of inhaled salbutamol. Aerosols were generated by an
ultrasonic nebulizer (Devilbiss, Somerset, PA, U.S.A.), the
output of which was set at 2.5 mL/min. The subjects were
asked to inhale the aerosols for 30 min in total. Subjects dis-
carded saliva into a bowl and mouth washed before each expec-
toration. Secretions collected during the first 5 min were dis-
carded to minimize squamous cell contamination. Subjects
were encouraged to cough deeply at 5 min intervals and any
other time they felt the need. Samples were collected in a
Petri dish. Sputum plugs of 1 mL were selected and kept at
4℃until processing.
The sputum was treated with 4 times their volume of 0.1%
dithiothreitol (DTT) (Sigma, St. Louis, MO, U.S.A.) at 37℃
for 15 min. This suspension was further diluted and mixed
with phosphate buffered saline (PBS) in a volume equal to
the sputum plus DTT for an additional 5 min. Cells were
centrifuged at 1,000 rpm for 10 min and then re-suspended
in PBS. Cyto-spins (CF-120, Tokyo, Japan) were prepared
on glass slides and the preparations were stained with Diff-
Quik (American Scientific Products, McGaw, IL, U.S.A.).
All cells were enumerated and counted, which allowed cal-
culation of both the squamous cell percentage of the total cell
sample and the epithelial, macrophage, neutrophil, eosinophil,
and lymphocyte percentages of the nonsquamous cells. At
least 200 nonsquamous cells on each slide were read by the
same investigator. Cytospins were also prepared on ProbeOn
Plus microscope slides (Fisher Scientific, Pittsburgh, PA,
U.S.A.) for immunocytochemical staining, and the prepara-
tions were fixed in methanol (Merck, Darmstadt, Germany)
at 4℃for 5 min and stored at -70℃until use.
Immunocytochemistry
Immunostaining was performed using the following mouse
IgG1 monoclonal antibodies: anti-CD1a (Clone 010; Dako,
Carpinteria, CA, U.S.A.), directed against the CD1a antigen
of DC (22), and EG2 (Kabi Pharmacia, Uppsala, Sweden),
directed against the activated form of human eosinophil cation-
ic protein.
The staining was detected by the LSAB�2 system (Dako).
Sputum slides were pretreated with a solution of hydrogen
peroxide and 15 mM sodium azide (Peroxidase blocking rea-
gent; Dako) to inhibit endogenous peroxidase activity. After
washes in Tris-buffered saline (TBS), a blocking solution con-
taining 0.25% casein (Protein block serum-free; Dako) was
applied to inhibit nonspecific staining. The slides were incu-
bated with the monoclonal antibodies in the optimal dilution
at room temperature for 30 min.
The monoclonal antibodies were used at working concen-
trations which were preliminarily determined (30  g/mL for
anti-CD1a and 1  g/mL for EG2). After washes in TBS, the
binding antibodies were labeled with biotinylated secondary
antibody (Dako) during 10 min incubation and made visible
using a streptavidin-horseradish-peroxidase complex detec-
tion system (Dako). Aminoethylcarbazole was applied as chro-
mogen, resulting in a red reaction product. Finally, slides were
rinsed with distilled water, counterstained with hematoxylin
solution (Accustain; Sigma), and mounted in glycerin gelatin.
Control slides were similarly treated either with the primary
antibody omitted or replaced by an unrelated mouse IgG1
monoclonal antibody (Dako). The percentage of CD1a+ DC
or EG2+cells was determined from a count of 1,500 or 500
nonsquamous cells under light microscopy, respectively.
Statistical analysis
Results were expressed as median (range). Differences bet-
ween groups were analyzed by the Mann-Whitney U test for
continuous variables and  2 tests for dichotomous variables.
The correlation between variables was examined by Spear-
man’s rank correlation coefficient. A value of p<0.05 was con-
sidered significant.
RESULTS
Demographic and functional characteristics of subjects
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normal controls, but those of nonatopic asthmatics were sig-
nificantly higher compared with normal controls (p<0.001).
There were more females in atopic (p<0.05) or nonatopic
asthmatics (p<0.05) than in normal controls, respectively.
Five current smokers were included in the study. The percent-
age of current smokers did not significantly differ between
atopic or nonatopic asthmatics and normal controls, respec-
tively. Nonatopic asthmatics had four ex-smokers who quit-
ted smoking 4.5 (2-15) yr before (Table 1).
There were no significant differences in sex, smoking habits,
and baseline FEV1 between atopic and nonatopic asthmatics,
except that the ages of atopic asthmatics were significantly
lower than those of nonatopic asthmatics (p<0.01). Metha-
choline bronchial provocation tests were performed in eight
atopic and six nonatopic asthmatics. The median values of PC20
were similar between atopic and nonatopic asthmatics (Table
1). Sputum induction was performed successfully and was
well tolerated in all subjects. A nonatopic asthmatic patient
with low baseline FEV1 of 1.2 L (38.9% of predicted) had a
postbronchodilator FEV1 of 1.52 L (55%) before sputum
induction.
Differential cell counts in induced sputum and 
immunocytochemistry
The median percentage of squamous cells in all subjects
was 6.1% (0-37%). The median percentage of macrophages
was significantly lower in atopic (p<0.05) or nonatopic asth-
matics (p<0.05) than in normal controls, respectively. The
median percentage of eosinophils was significantly higher in
atopic (p<0.001) or nonatopic asthmatics (p<0.001) than in
normal controls, respectively. There were no significant differ-
ences in the median percentages of lymphocytes, neutrophils,
and epithelial cells between atopic (p>0.05, respectively) or
Data were expressed as median (range) unless otherwise noted. *p<
0.05 and 
� p<0.001 compared with normal controls. 
� p<0.01 compared
with nonatopic asthmatics.
Atopic asthmatics
(n=9)
Nonatopic 
asthmatics (n=12)
Normal controls
(n=10)
Age (yr) 28 (18-58)
� 59 (31-73)
� 24 (22-30)
Female, n (%) 4 (44)* 5 (42)* 0 (0)
Smoking habits, n (%)
Current 1 (11) 3 (25) 1 (10.0)
Ex 0 (0) 4 (33) 0 (0)
None 8 (89) 5 (42) 9 (90)
FEV1 (L) 2.8 (1.6-4.6) 2.6 (1.2-3.8) (-
FEV1 83.4 (51.0-94.6) 86.1 (38.9-127.4) (-
(% of predicted)
PC20 (mg/mL) 2.2 (0.02-20.5) 4.6 (0.4-23.5) (-
(n=8) (n=6)
Table 1. Characteristics of the subjects
Data were expressed as median (range). *p<0.05 and 
� p<0.001 com-
pared with normal controls.
Atopic asth-
matics (n=9)
Nonatopic 
asthmatics (n=12)
Normal controls
(n=10)
Macrophages (%) 56.6 (28.3-82.6)* 42.4 (8.3-78.2)* 81.7 (54.6-95.0)
Lymphocytes (%) 0.4 (0.0-1.4) 0.4 (0.0-3.9) 0.2 (0.0-0.7)
Neutrophils (%) 10.0 (1.5-40.5) 20.3 (1.3-82.4) 10.4 (0.3-44.7)
Eosinophils (%) 3.4 (2.8-26.5)
� 2.5 (0.0-55.8)
� 0.0 (0.0-0.3)
Epithelial cells (%) 11.2 (5.1-52.8) 6.5 (2.3-31.6) 7.1 (0.6-26.8)
Table 2. Sputum differential cell percentages
Fig. 1. Immunocytochemical staining with anti-CD1a (A) and EG2 (B) (×400). CD1a+ dendritic cell (arrow) and EG2+ cell (arrow) were
shown in the induced sputum of an asthmatic patient.
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nonatopic asthmatics (p>0.05, respectively) and normal con-
trols (Table 2).
CD1a+ DC (Fig. 1A) and EG2+ cells (Fig. 1B) were evi-
dent in the induced sputum. No immunostaining was iden-
tified either in the absence of primary antibody or in the pres-
ence of the mouse IgG1 isotype control. In one nonatopic asth-
matic patient, EG2 immunostaining was not done because of
a paucity of sputum cells. The median percentage of CD1a+
DC was significantly higher in atopic (0.27% [0.13-0.93%],
p<0.01) or nonatopic asthmatics (0.17% [0-1.4%], p<0.05)
than in normal controls (0.07% [0-0.2%]), respectively (Fig.
2A). The median percentage of EG2+ cells was significant-
ly higher in atopic (0.6% [0-5.6%], p<0.01) or nonatopic
asthmatics (0.8% [0-3%], p<0.01) than in normal controls
(0% [0-0.2%]), respectively (Fig. 2B).
There were no significant differences in the percentages of
sputum macrophages, lymphocytes, neutrophils, eosinophils,
epithelial cells, CD1a+DC, and EG2+cells between atopic
and nonatopic asthmatics (p>0.05, respectively) (Table 2 and
Fig. 2).
When the analyses were performed according to sex or
smoking habits, the percentage of CD1a+ DC did not dif-
fer between male and female asthmatics (0.23% [0-1.40%]
vs. 0.27% [0-1.07%], p>0.05). In all asthmatics, the per-
centage of CD1a+ DC tended to be lower in four current
smokers compared with the rest (0.07% [0-0.53%] vs. 0.27%
[0.07-1.4%], p=0.08)
Correlation between DCs and activated eosinophils in
induced sputum
The percentage of CD1a+ DC did not correlate with that
of macrophages (Rs=0.07, p>0.05), epithelial cells (Rs=-0.21,
p>0.05), neutrophils (Rs=0.06, p>0.05), eosinophils (Rs=
-0.14, p>0.05), or lymphocytes (Rs=0.36, p>0.05) in all asth-
matics, respectively. However, there was a significant corre-
lation between the percentages of CD1a+ DC and EG2+
cells in all asthmatics (Rs=0.62, p=0.004, n=20). When the
analyses were limited to atopic or nonatopic asthmatics, the
percentage of CD1a+DC was correlated with that of EG2+
cells in atopic (Rs=0.65, p=0.06, n=9) or nonatopic asthmat-
ics (Rs=0.64, p=0.03, n=11), respectively (Fig. 3). Addition-
ally, the percentage of CD1a+DC did not correlate with the
ages in all asthmatics (Rs=-0.12, p>0.05).
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DISCUSSION
We demonstrated that the number of DCs was significantly
increased in the induced sputum of both atopic and nonatopic
asthmatics compared with normal controls, and there was
the close relationship between DCs and activated eosinophils
in asthmatics. Sputum induction by inhalation of hyperton-
ic saline solution has been validated and is now widely used
to study airway secretions in patients with airway diseases
such as asthma. This method, which is inexpensive and does
not require complex instrumentation, has the advantages of
being less invasive than bronchoscopy and bronchoalveolar
lavage. Its safety has been studied in patients with asthma and
found to be good even in patients with more severe disease
(23, 24). The reproducibility of the method has been exten-
sively assessed and found to be good with respect to cell counts
and a number of soluble markers of inflammation (15, 16).
Therefore, the first finding of showing the presence of DCs
in the induced sputum can prompt future studies on DCs
using the sputum in asthmatics.
The increased numbers of DCs in the airways of atopic asth-
matics are compatible with their role of professional APCs
involved in the allergen dependent activation of T lympho-
cytes in the lower respiratory tract of asthmatics (3). However,
a few studies have shown the increased number of DCs in the
bronchial mucosa of nonatopic asthmatics (13, 14). Our data
extended their findings by showing that the increased num-
ber of DCs was evident in the induced sputum of nonatopic
asthmatics, and the number of DCs was similar between atopic
and nonatopic asthmatics. These observations suggest that
DCs may play a role in the pathogenesis of nonatopic asthma
as well as atopic asthma, although further investigations are
needed.
It has been demonstrated that DCs are essential for the
acquisition of effector function in memory Th2 cells and the
subsequent development of eosinophilic airway inflamma-
tion in a mouse model of asthma (6), which may explain in
part our finding of the relationship between DCs and activat-
ed eosinophils in the airways of atopic asthmatics. Lambrecht
et al. (7). have demonstrated that the kinetics of increase of
DCs after repeated exposure to antigen closely resemble those
of Th2 cells and eosinophils in bronchoalveolar lavage fluid
of previously sensitized rats, suggesting that these cells are
attracted into the airways by similar mechanisms. Allergic
airway inflammation is indeed accompanied by the local release
of chemokines and mediators such as eotaxin, regulated on
activation, normal T cells expressed and secreted, macrophage
inflammatory protein-1 , monocyte chemotactic protein
(MCP)-1, MCP-3, which can attract DCs (25, 26) as well as
eosinophils. Schon-Hegrad et al. (27) reported that chronic
eosinophilic airway inflammation in rats was accompanied
by an increase of the intramucosal DCs network at areas of
eosinophilic infiltration. In addition, DCs may produce chemo-
kines that preferentially attract recently activated Th2 cells
(28, 29), indicating that they might contribute directly to the
ongoing eosinophilic inflammation. Recently, Parameswaran
et al. (8) have demonstrated that CysLTs play a role in the
migration of DCs from blood to the airway in asthma. CysLTs
released from activated eosinophils (9) may contribute to DC
trafficking, which may explain in part our finding that the
DC number was correlated with only the number of activat-
ed eosinophils, but not the differential count of eosinophils.
Collectively, it is probable that DCs may contribute to the
ongoing eosinophilic inflammation in asthmatic airways, and
vice versa. The hypothesis might explain why there is the
relationship between DCs and activated eosinophils in the
airways of nonatopic as well as atopic asthmatics.
Like other previous studies (5, 10-12, 14), we used a mono-
clonal antibody directed against CD1a antigen to identify
airway DCs. Other cells known to express this marker are
either present in the airways at very low frequency (B-lym-
phocytes) (30) or absent altogether (cortical thymocytes).
In the present study, there were significant differences in
age and sex among the three groups, which might affect our
results. However, this may be not the case, based on our find-
ings that the number of DCs did not differ according to age or
sex in all asthmatics. The present study included five current
smokers in total, although there was no significant difference
in the number among the three groups. Cigarette smoking
might contribute to the increased number of DCs in the air-
ways of asthmatics (31). However, the number of DCs was
lower than expected in our current smokers, which could be
explained by the small sample size of studied patients.
In conclusion, although our results referred to a limited
number of asthmatics, we demonstrated that the increased
number of DCs was evident in the induced sputum of both
atopic and nonatopic asthmatics, and the DC number was
related to the activated eosinophil count, which suggests that
DCs may contribute to the ongoing eosinophilic inflamma-
tion in asthmatic airways, and vice versa. Further studies are
needed to elucidate the precise mechanism for the relation-
ship in asthma.
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